Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc (BHC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,686,798
  • Shares Outstanding, K 352,126
  • Annual Sales, $ 8,601 M
  • Annual Income, $ -1,788,000 K
  • 60-Month Beta 1.23
  • Price/Sales 0.56
  • Price/Cash Flow 1.30
  • Price/Book 4.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.90
  • Number of Estimates 6
  • High Estimate 1.04
  • Low Estimate 0.75
  • Prior Year 1.03
  • Growth Rate Est. (year over year) -12.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.15 +19.37%
on 03/18/20
23.55 -43.48%
on 03/04/20
-9.71 (-42.18%)
since 03/03/20
3-Month
11.15 +19.37%
on 03/18/20
30.39 -56.20%
on 01/17/20
-16.11 (-54.76%)
since 01/03/20
52-Week
11.15 +19.37%
on 03/18/20
31.97 -58.37%
on 12/13/19
-11.49 (-46.33%)
since 04/03/19

Most Recent Stories

More News
VRX Investor Alert: Kyros Law is Filing Legal Claims on Behalf of Valeant Pharmaceuticals (NYSE: VRX), now Bausch Health Companies (NYSE: BHC) Investors

Kyros Law Offices is alerting investors of Valeant Pharmaceuticals (NYSE: VRX), now Bausch Health Companies (NYSE: BHC) that it is filing legal claims against the company on behalf of investors.

VRX : 23.40 (-3.43%)
BHC : 13.31 (-1.99%)
Why Is Bausch (BHC) Down 46.5% Since Last Earnings Report?

Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BHC : 13.31 (-1.99%)
Topical Drug Delivery Market 2020 Demand, Current Trends, Growth Analysis, Competitor Analysis, Future Forecast 2025

The Global is segmented on the lines of its product type, facility of use, route of administration and regional. Based on product type segmentation it covers formulation, devices. Based on facility of...

BAYRY : 14.3400 (-0.62%)
CRRTF : 0.3925 (-3.56%)
NVS : 83.64 (+0.05%)
VRX.TO : 30.80 (-3.33%)
BHC : 13.31 (-1.99%)
Aerie's (AERI) Q4 Loss Wider Than Expected, Revenues Beat

Aerie (AERI) reports a wider loss in the fourth quarter, while sales surpass expectations.

PFE : 33.64 (+2.34%)
AGN : 175.71 (-1.03%)
AERI : 12.17 (-6.96%)
BHC : 13.31 (-1.99%)
Bausch's (BHC) Q4 Earnings Match Estimates, Revenues Miss

Bausch (BHC) reports mixed fourth-quarter results, with earnings meeting expectations but sales missing the same.

UTHR : 92.74 (-0.84%)
PCRX : 30.80 (-5.46%)
XNCR : 28.96 (-2.82%)
BHC : 13.31 (-1.99%)
Should You Buy Bausch Health (BHC) Ahead of Earnings?

Bausch Health (BHC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

BHC : 13.31 (-1.99%)
Should Value Investors Pick Bausch Health (BHC) Stock Now?

Is Bausch Health (BHC) a great pick from the value investor's perspective right now? Read on to know more.

BHC : 13.31 (-1.99%)
Aerie's (AERI) Application for Roclanda Accepted in Europe

European authorities accept Aerie's (AERI) filing for its second ophthalmology drug, Roclanda.

AGN : 175.71 (-1.03%)
PFE : 33.64 (+2.34%)
AERI : 12.17 (-6.96%)
BHC : 13.31 (-1.99%)
5 Reasons Why Ironwood Stock Should Be in Your Portfolio

We provide five reasons which makes Ironwood (IRWD) a good investment option in 2020.

AZN : 43.96 (+0.46%)
AGN : 175.71 (-1.03%)
IRWD : 9.87 (-2.28%)
BHC : 13.31 (-1.99%)
Bausch's (BHC) Arazlo Gets FDA Approval for Acne Vulgaris

Bausch (BHC) gets FDA approval for Arazlo Lotion for the topical treatment of acne vulgaris in patients nine years of age or older.

ALKS : 14.12 (+0.71%)
INVA : 11.55 (-4.70%)
ANIK : 27.83 (-6.23%)
BHC : 13.31 (-1.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Trade BHC with:

Business Summary

Bausch Health Companies Inc. develops and distributes drugs. It develops drugs for unmet medical needs in central nervous system disorders and distributes generic and branded generic drugs primarily in Latin America and Eastern Europe. Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals,...

See More

Key Turning Points

2nd Resistance Point 14.54
1st Resistance Point 13.92
Last Price 13.31
1st Support Level 12.83
2nd Support Level 12.36

See More

52-Week High 31.97
Fibonacci 61.8% 24.02
Fibonacci 50% 21.56
Fibonacci 38.2% 19.10
Last Price 13.31
52-Week Low 11.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar